Register Now
Why register?
 The leading web portal for pharmacy resources, news, education and careers August 30, 2014
Pharmacy Choice - News - Generic Drugs - August 30, 2014

Pharmacy News

 Generic Drugs
Current Articles | 7 - 30 Days Old | 30 - 90 Days Old | Over 90 Days
Articles(s): 1 - 5 of 5     Go To Page:

8/28/14 - Studies from Federal University Have Provided New Information about Science and Public Policy (Brazilian pharmaceutical industry and generic drugs...
Our news editors obtained a quote from the research from Federal University, "In this paper, we evaluate the unplanned impacts from the introduction of generic drugs, particularly with respect to the business scale and innovation. For more information on this research see: Brazilian pharmaceutical industry and generic drugs policy: Impacts on struc
8/27/14 - Amneal Pharmaceuticals Announces Four New Generics
By a News Reporter-Staff News Editor at Biotech Week Amneal Pharmaceuticals' fast-growing portfolio of approved generic drugs is expanding once again with the launch of four new medications. Representing multiple therapeutic categories, these products accounted for $900 million annually in U.S. sales as of June 2014, according to IMS Health marke
8/25/14 - Mylan Launches Generic Xeloda Tablets
By a News Reporter-Staff News Editor at Pharma Business Week Mylan Inc. announced that it has launched Capecitabine Tablets USP, 150 mg and 500 mg, the generic version of Genentech's Xeloda Tablets. Capecitabine Tablets USP, 150 mg and 500 mg, had U.S. sales of approximately $773.8 million for the 12 months ending June 30, 2014, according to I
8/25/14 - Studies from M. Michallet et al in the Area of Clinical Trials and Studies Described (BiOsimilaRs in the management of anaemia secondary to...
According to news originating from Meudon, France, by NewsRx correspondents, research stated, "The approval of epoetin biosimilars in the European Union requires extensive scientific evaluation and stringent regulatory procedures, including post-marketing studies. Our news journalists obtained a quote from the research, "Patients> 18 years with CIA
8/23/14 - Heritage Pharmaceuticals Inc. Signs Exclusive Development Supply & Distribution Agreement with Dexcel Ltd.
By a News Reporter-Staff News Editor at Marketing Weekly News Heritage Pharmaceuticals Inc. has signed an Exclusive Development, Supply& Distribution Agreement with Dexcel Ltd. for an Extended Release ANDA drug product. The product generates generic annual U.S. sales of approximately $60 million, per IMS Health. Keywords for this news article inc
Articles(s): 1 - 5 of 5     Go To Page:

© 2014 Thomson Reuters. All rights reserved.

Pharmacy News Index
  Drug Delivery Systems
  FDA Final Approvals
  Front Page Healthcare News
  Generic Drugs
  Hospital Industry
  Internet Pharmacy
  IT in Healthcare
  Medicare & Medicaid
  Over-the-Counter Drugs
  Pharm Industry Trends and Policy
  Pharmaceutical Development
  Pharmaceutical Industry


The Diversion of Controlled Substances and the Law
This lesson is supported by:
Drug Therapy Management Series Part III: Geriatric Disorders
This lesson is supported by:

Special Announcement

Free Membership
Enjoy Drug Search, industry newsletters and more...

Websites »
Copyright © 2009 Pharmacy Choice - All rights reserved.
Terms and Conditions | Privacy Statement